
April 14 (Reuters) - Longevity Health Holdings Inc XAGE.O:
LONGEVITY HEALTH HOLDINGS ANNOUNCES EXECUTION OF MERGER AGREEMENT WITH 20/20 BIOLABS
LONGEVITY HEALTH HOLDINGS INC - COMBINED COMPANY TO TRADE ON NASDAQ UNDER SYMBOL 'XAGE'
LONGEVITY HEALTH HOLDINGS INC - POST-CLOSING EQUITY VALUATION OF COMBINED CO EXPECTED TO BE $99 MILLION
LONGEVITY HEALTH HOLDINGS INC - MERGER EXPECTED TO DOUBLE LONGEVITY'S FY 2025 REVENUE TO $7-8 MILLION
LONGEVITY HEALTH HOLDINGS INC - RAJIV SHUKLA TO REMAIN CHAIRMAN, JONATHAN COHEN TO BE APPOINTED CEO
LONGEVITY HEALTH HOLDINGS INC - MERGER EXPECTED TO CLOSE IN Q3 2025
LONGEVITY HEALTH HOLDINGS INC - 20/20 PRE-MERGER STOCKHOLDERS TO OWN 50.1% OF COMBINED COMPANY POST-MERGER